Clinical Trial Update: Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating human amniotic membrane for the management of stage II medication-related osteonecrosis of the jaw is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medication-related Osteonecrosis of the Jaw

Drugs mentioned

• Human Amniotic Membrane (human amniotic membrane)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Osteonecrosis Due to Drugs, Jaw | Phase 2 | Status: RECRUITING